CareMax Inc

CareMax — Q3 2021 Earnings Presentation

16 slides from CareMax's earnings presentation, Nov 15, 2021

  1. Slide 1: Third Quarter 2021 Earnings Presentation

    Third Quarter 2021 Earnings Presentation November 15, 2021 EX-99.2

  2. Slide 2: Disclaimer

    Disclaimer Presentation This presentation (“Presentation”) is for informational purposes only and does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation to purchase any equity, debt or other financial instruments, of CareMax, Inc. (“CareMax” or the “Company”) or

  3. Slide 3: CareMax at a Glance

    CareMax at a Glance 26K+ Medicare Advantage Members 2011 Year Founded 42 Medical Centers 95+ Employed Providers 68K+ Total Members We are… A founder-led, technology-enabled, whole person healthcare platform providing value-based care and chronic disease management to seniors. Our mission… Is to empo

  4. Slide 4: Third Quarter 2021 Update

    Third Quarter 2021 Update Medical Expense Ratio reflects external provider costs divided by Medicare and Medicaid risk-based revenues. Strategic Highlights Closed the acquisition of DNF Medical Centers on September 1, 2021, adding approximately 4,000 Medicare lives and expanding CareMax’s footprint

  5. Slide 5: Our Medical Center Footprint and Medicare Advantage Membership Have Scaled Quickly

    Our Medical Center Footprint and Medicare Advantage Membership Have Scaled Quickly Includes potential additional centers and membership from acquisitions in our pipeline. Medical Centers Medicare Advantage Members 1 1 ~7.5x ~10x

  6. Slide 6: We Have a Track Record of Meaningfully Improving the Health Outcomes and Costs

    We Have a Track Record of Meaningfully Improving the Health Outcomes and Costs of the Highest Acuity Patients Figure reflects legacy CareMax as of year-end 2020. Reflects CareMax patients enrolled in HealthSun health plans for 2019 dates of service. External Provider Cost PMPM by Member Tenure2 (14)

  7. Slide 7: We Are Well Positioned to Execute Our De Novo Strategy in 22

    We Are Well Positioned to Execute Our De Novo Strategy in 2022 We have conducted a rigorous prioritization of sites in our pipeline based on detailed diligence and forecasted return on capital We have onboarded two Market Presidents to oversee pre-opening expansion efforts in priority states We have

  8. Slide 8: De Novo Centers Offer Compelling Returns on Investment and Require Limited Upfront Capital

    De Novo Centers Offer Compelling Returns on Investment and Require Limited Upfront Capital Includes initial buildout costs and operating losses up to platform contribution breakeven. Initial CareMax operating losses include self-financed FF&E and incremental costs associated with payor partner and t

  9. Slide 9: Excluding the Impact of COVID, Our Underlying Business Has Continued to Scale Profitably

    Excluding the Impact of COVID, Our Underlying Business Has Continued to Scale Profitably Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Platform contribution defined as revenue less external provider costs and cost of c

  10. Slide 10: We Have Successfully Managed COVID Utilization Among Our Patients Despite the Delta Surge

    We Have Successfully Managed COVID Utilization Among Our Patients Despite the Delta Surge in Florida CareMax and IMC Medicare only. COVID Admissions More Benign Than Expected1 In-Person PCP Visits Have Fully Recovered1 3Q21 COVID hospitalizations among our Medicare members peaked at a lower level th

  11. Slide 11: Third Quarter 2021 Financial Supplement

    Third Quarter 2021 Financial Supplement

  12. Slide 12: Reconciliation to Non-GAAP Revenue and Platform Contribution

    Reconciliation to Non-GAAP Revenue and Platform Contribution Reflects impact of business combination of CareMax, IMC, and Care Holdings and other pro forma adjustments as may arise from the combination. 3Q20 Non-GAAP Reconciliation 3Q21 Non-GAAP Reconciliation 1 1

  13. Slide 13: Historical Non-GAAP Financial Summary

    Historical Non-GAAP Financial Summary Note: Figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Includes pre-opening costs and operating losses incurred by de novo centers up to 12 months after

  14. Slide 14: Reconciliation to Adjusted EBITDA

    Reconciliation to Adjusted EBITDA Note: Pro forma and non-GAAP figures give effect to the combinations of CareMax, IMC, and Care Holdings as if they had occurred in historical periods. Totals may not sum due to rounding. Pro forma net income replaces historical interest expense and D&A with go-forwa

  15. Slide 15: Capitalization and Liquidity

    Capitalization and Liquidity Excludes unvested warrants. Warrants have a strike price of $11.50/share and (other than the Related warrants) are subject to a $18.00 redemption cap. Shares issuable through warrants assumes treasury stock method. 50% of earnout shares are issuable if the volume weighte

  16. Slide 16: Q&A

    Caremax Q&A

CareMax — Q3 2021 Earnings Presentation on 6ix